Title : Dasatinib in solid tumors.

Pub. Date : 2010 Mar

PMID : 20113198






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IMPORTANCE OF THE FIELD: Dasatinib is an oral, potent adenosine triphosphate-competitive inhibitor of multiple tyrosine kinases including BCR-ABL, c-KIT, platelet-derived growth factor receptor, and Src family kinases (SFKs). Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens